For its second fiscal quarter (ending June 30), DXP Enterprises Inc (NASDAQ: DXPE) has reported a -5% decline in E.P.S. from $1.11 a year ago to $1.05 in the current quarter. Relative to the consensus […]
For its second fiscal quarter (ending June 30), Century Aluminum Co (NASDAQ: CENX) has reported a -138% decline in E.P.S. from $0.08 a year ago to $-0.03 in the current quarter. This result fell short […]
Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock closed at $18.30 on 8/8/24 after a major increase of 12.8%. Moreover, trading volume in this advance was exceptionally high at 227% of normal. The stock has risen 6.1% […]
America’s Car-Mart Inc (NASDAQ: CRMT). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down. Important negative […]
Recent extremely meaningful negative changes in investment behavior have impacted Advanced Energy Industries Inc. (NASDAQ: AEIS): the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down. Recent […]
For its second fiscal quarter (ending June 30), Sarepta Therapeutics Inc (NASDAQ: SRPT) has reported E.P.S. of $0.07 compared to $-0.27 a year ago. This performance was $-0.40 short of the consensus estimate of $0.47. […]
RadNet Inc (NASDAQ: RDNT) has reported a loss for its second fiscal quarter (ending June 30) of $-0.04 versus $0.14 for the same period a year ago — a decline of -129%. This performance was […]
ModivCare Inc (NASDAQ: MODV) has reported E.P.S. of $-9.07 for its second fiscal quarter (ending June 30) versus $-13.47 for the same period a year ago. Relative to the consensus estimate of $0.76, this was […]
MKS Instruments Inc (NASDAQ: MKSI) has reported E.P.S. of $0.34 for its second fiscal quarter (ending June 30) versus $-26.49 for the same period a year ago. Relative to the consensus estimate of $1.07, this […]
For its second fiscal quarter (ending June 30), Intra-Cellular Therapies Inc (NASDAQ: ITCI) has reported E.P.S. of $-0.16 compared to $-0.45 a year ago. This performance was $0.02 better than the consensus estimate of $-0.18. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research